Our study has uncovered a novel miR‐429‐CRKL‐Raf/MEK/ERK regulatory pathway in erythroid differentiation of CML and partially elucidated the molecular mechanism underlying erythroid differentiation in CML cells. Here, MAP2K7 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.